CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong
· Delayed Price · Currency is HKD 2.600
+0.110 (4.42%)
At close: Mar 10, 2026
CANbridge Pharmaceuticals Employees
CANbridge Pharmaceuticals had 67 employees as of December 31, 2024. The number of employees decreased by 33 or -33.00% compared to the previous year.
Employees
67
Change (1Y)
-33
Growth (1Y)
-33.00%
Revenue / Employee
1.52M HKD
Profits / Employee
-3.31M HKD
Market Cap
1.27B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 67 | -33 | -33.00% |
| Dec 31, 2023 | 100 | -17 | -14.53% |
| Dec 31, 2022 | 117 | -66 | -36.07% |
| Dec 31, 2021 | 183 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HighTide Therapeutics | 57 |
| Beijing Biostar Pharmaceuticals | 131 |
| Kintor Pharmaceutical | 136 |
| Immunotech Biopharm | 173 |
| Shanghai Bio-heart Biological Technology | 70 |
| Mabpharm | 383 |
| Cutia Therapeutics | 298 |
| Wuhan YZY Biopharma | 106 |
CANbridge Pharmaceuticals News
- 7 months ago - China's Push To Expand Access To Costly Therapies And A Partnership Deal Boost Rare Drugs Maker - But Is It Enough? - Benzinga